Frontiers | CD38 Is Robustly Induced in Human Macrophages and Monocytes in Inflammatory Conditions
Discrimination of M1 and M2 macrophages via CD38 and Egr2 flow... | Download Scientific Diagram
Novel Markers to Delineate Murine M1 and M2 Macrophages | PLOS ONE
Cells | Free Full-Text | Roles of CD38 in the Immune Response to Infection
Frontiers | CD38: A Significant Regulator of Macrophage Function
CD38 expression in macrophages mediate "inflammaging." The senescence... | Download Scientific Diagram
PTIP governs NAD+ metabolism by regulating CD38 expression to drive macrophage inflammation - ScienceDirect
CD38 expression in human M1 macrophages and analysis of the de novo NAD... | Download Scientific Diagram
CD38 in the age of COVID-19: a medical perspective | Physiological Reviews
Novel Markers to Delineate Murine M1 and M2 Macrophages | PLOS ONE
CD38 expression in macrophages in HCC tissues was validated using flow... | Download Scientific Diagram
Aging-related inflammation driven by cellular senescence enhances NAD consumption via activation of CD38+ pro-inflammatory macrophages | bioRxiv
Identification of macrophage activation-related biomarkers in obese type 2 diabetes that may be indicative of enhanced respiratory risk in COVID-19 | Scientific Reports
Genes | Free Full-Text | Macrophage Polarization in Atherosclerosis
CD38 - Wikipedia
Aging-related inflammation driven by cellular senescence enhances NAD consumption via activation of CD38+ pro-inflammatory macrophages | bioRxiv
Novel Markers to Delineate Murine M1 and M2 Macrophages | PLOS ONE
Novel Markers to Delineate Murine M1 and M2 Macrophages | PLOS ONE
Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages | Nature Metabolism
Frontiers | Expression of CD38 on Macrophages Predicts Improved Prognosis in Hepatocellular Carcinoma
Frontiers | CD38 Is Robustly Induced in Human Macrophages and Monocytes in Inflammatory Conditions
Frontiers | CD38: A Significant Regulator of Macrophage Function
Frontiers | Expression of CD38 on Macrophages Predicts Improved Prognosis in Hepatocellular Carcinoma
M1 Macrophage Flow Cytometry Panel: R&D Systems
Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma | Journal for ImmunoTherapy of Cancer
